PUMA BIOTECHNOLOGY, INC. : PBYI Stock Price | US74587V1070 | MarketScreener
Should Puma Biotechnology Stock Be in Your Portfolio? | The Motley Fool
Here's Why Puma Biotechnology Tumbled Today | The Motley Fool
Is Puma off the cancer M&A list? With Nerlyx marketing deal, some investors think so | Fierce Pharma
Puma Shares Soar 81% Over 2 Days - Los Angeles Business Journal
Puma Biotechnology - Crunchbase Company Profile & Funding
Stocks to Watch: Dropbox, Nike, Tronc, Qualcomm, Puma Biotechnology, Invitation Homes, Universal Display - WSJ
Puma Biotech agrees to pay investors $54.2 mln in fraud case | Reuters
Former Puma Biotech executive gets U.S. prison term for insider trading | Reuters
Puma Biotechnology Reports Fourth Quarter and Full Year Financial Results | Business Wire
Why Puma Biotech Could Get Acquired Between July to September of This Year | BioSpace
Federal Jury Awards Puma Biotechnology Investors Damages in Securities Class-Action Verdict - Los Angeles Business Journal
Why Puma Biotechnology's Shares Jumped 20% on Monday | The Motley Fool
Puma Biotech Surges, Defying Yellen
Puma Bio Bulls Win Monday's FDA Neratinib Review, Ahead of Wednesday's Advisory Panel Vote - TheStreet
PBYI Stock Price and Chart — NASDAQ:PBYI — TradingView
PBYI | Puma Biotechnology Inc. Stock Overview (U.S.: Nasdaq) | Barron's
Articles about Puma Biotechnology
Puma Biotechnology
Puma shares nearly triple on drug news, but options smell 'fishy'
Puma Biotechnology Inc (NASDAQ:PBYI) Share Price | RNS News, Quotes, & Charts | PBYI
Puma Biotechnology (NASDAQ:PBYI) Stock Price News
Supernus, Puma Among 5 Big Biotech Stock Winners, Losers Monday | Stock News & Stock Market Analysis - IBD
Puma Biotech (PBYI) Up More Than 95% in 3 Months: Here's Why
Puma Biotechnology Reports Fourth Quarter and Full Year Financial Results | Business Wire
Puma Biotechnology, Inc. (PBYI) Stock Price Today, Quote & News | Seeking Alpha
Puma Biotechnology, Inc. Insider Trading & Ownership Structure - Simply Wall St
Puma Biotech (PBYI) Stock up as Q2 Earnings & Sales Beat
Puma Biotech (NYSE: PBYI) Stock Skyrockets 300% on Breast Cancer Breakthrough
Puma Biotechnology stock could quadruple, says Jim Cramer
